MyFinsight
Home
Blog
About
Short-term investments
$446,549K
(94.77%↑ Y/Y)
Cash and cash
equivalents
$196,577K
(346.70%↑ Y/Y)
Prepaid expenses and
other current assets
$10,668K
(100.38%↑ Y/Y)
Total current assets
$653,794K
(134.67%↑ Y/Y)
Long-term investments
$30,763K
(1806.01%↑ Y/Y)
Other non-current
assets
$16,289K
(38.08%↑ Y/Y)
Operating lease
right-of-use assets, net
$821K
(-18.71%↓ Y/Y)
Property and equipment,
net
$23K
(-62.30%↓ Y/Y)
Total assets
$701,690K
(139.42%↑ Y/Y)
Total liabilities and
stockholders' equity
$701,690K
(139.42%↑ Y/Y)
Total liabilities
$454,593K
(750.36%↑ Y/Y)
Total stockholders'
equity
$247,097K
(3.12%↑ Y/Y)
Accumulated deficit
-$957,571K
(-102.37%↓ Y/Y)
Accumulated other
comprehensive loss
-$1,141K
(-1113.83%↓ Y/Y)
Total long-term
liabilities
$388,775K
Total current
liabilities
$65,818K
(23.62%↑ Y/Y)
Additional paid-in capital
$1,205,803K
(69.14%↑ Y/Y)
Common stock, par value
0.0001 per share...
$6K
(50.00%↑ Y/Y)
Convertible senior notes,
net
$222,956K
Royalty obligation
$91,737K
Senior secured term
loan, net
$74,060K
Operating lease
liabilities, less current...
$22K
(-89.77%↓ Y/Y)
Accrued expenses
$57,406K
(28.94%↑ Y/Y)
Accounts payable
$7,589K
(-4.31%↓ Y/Y)
Operating lease
liabilities, current
$823K
(3.78%↑ Y/Y)
Back
Back
Balance Sheet
Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma, Inc. (ZBIO)
source: myfinsight.com